0001403752 false 0001403752 2021-05-05 2021-05-05




Washington, D.C. 20549







Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 5, 2021



Zymeworks Inc.

(Exact name of registrant as specified in its charter)




British Columbia, Canada   001-38068   98-1398788
(State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.)


Suite 540, 1385 West 8th Avenue, Vancouver, British Columbia,
  V6H 3V9
(Address of principal executive offices)   (Zip Code)

(604) 678-1388

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class


Trading Symbol(s)


Name of each exchange on which registered

Common Shares, no par value per share   ZYME   New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



ITEM 5.07


The following information is filed pursuant to Item 5.07, “Submission of Matter to a Vote of Security Holders.”

On May 5, 2021, Zymeworks Inc. (the “Company”), held its 2021 annual meeting of shareholders (the “Annual Meeting”). A total of 29,226,661 of the holders of the Company’s common shares were present or represented by proxy at the meeting, representing approximately 63.31% of the Company’s 46,164,051 common shares that were outstanding and entitled to vote at the Annual Meeting as of the record date of March 12, 2021. Set forth below are the matters acted upon by the Company’s shareholders at the Annual Meeting, and the final voting results on each matter. Each of the proposals are described in further detail in the Company’s definitive proxy statement dated March 23, 2021, filed with the Securities and Exchange Commission on March 23, 2021.

Proposal 1



The shareholders voted by way of ballot and the following nominees were elected as directors to serve until their term expires or until their successors are duly elected or appointed.


Nominee    Votes For    % Votes For    Votes Withheld   

% Votes



Broker Non-


Susan Mahony

   19,286,855    71.48%    7,695,418    28.52%    2,244,388

Kelvin Neu

   19,377,998    71.82%    7,604,275    28.18%    2,244,388

Ali Tehrani

   19,375,651    71.81%    7,606,622    28.19%    2,244,388

Proposal 2



The shareholders voted on an advisory and non-binding basis by way of ballot and approved the compensation of the Company’s named executive officers. There were 2,244,388 broker non-votes for this proposal.


Votes For



%Votes For



Votes Against



% Votes Against



Votes Abstaining






   89.30 %    2,607,651    9.66 %    279,529    1.04 %

In the Company’s proxy statement with respect to the Company’s 2020 annual meeting of shareholders, filed on March 23, 2020, the Company disclosed that its Board of Directors intended to hold say-on-pay votes in the future in accordance with the alternative that received the most shareholder support at the Company’s 2020 annual meeting of shareholders. As reported in the Company’s Current Report on Form 8-K filed on May 8, 2020, at the Company’s 2020 annual meeting of shareholders, the shareholders selected every year as the preferred frequency of holding future advisory votes on the compensation of the Company’s named executive officers.

Proposal 3



The shareholders voted by way of ballot and KPMG LLP, chartered professional accountants, were reappointed as auditors for the Company until the close of the next annual general meeting of shareholders and the directors were authorized to determine their remuneration.


Votes For



%Votes For



Votes Withheld



% Votes Withheld



   98.99 %    296,499    1.01 %

A report outlining the voting results described above is filed as Exhibit 99.1 hereto.


ITEM 7.01


On May 6, 2021, the Company issued a press release announcing the voting results of its Annual Meeting, which was filed with the Canadian securities regulatory authorities in Canada on the System for Electronic Document Analysis and Retrieval (“SEDAR”) at www.sedar.com. A copy of this press release is attached as Exhibit 99.2 hereto.

The information provided under this Item (including Exhibit 99.2, attached hereto) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

ITEM 9.01


(d) Exhibits


Exhibit No.          



Report on Voting Results.


Press Release issued by Zymeworks Inc. on May 6, 2021.


Cover Page Interactive Data File (embedded as Inline XBRL document).




Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.




Date: May 6, 2021     By:  

/s/ Neil A. Klompas

    Name:   Neil A. Klompas

Executive Vice President, Business

Operations and Chief Financial Officer

Zymeworks (NYSE:ZYME)
Historical Stock Chart
From Sep 2021 to Oct 2021 Click Here for more Zymeworks Charts.
Zymeworks (NYSE:ZYME)
Historical Stock Chart
From Oct 2020 to Oct 2021 Click Here for more Zymeworks Charts.